Complexity of vaginal microflora as analyzed by PCR denaturing gradient gel electrophoresis in a patient with recurrent bacterial vaginosis. by Devillard, Estelle et al.
CLINICAL STUDY
Complexity of vaginal microﬂora as analyzed by PCR denaturing
gradient gel electrophoresis in a patient with recurrent bacterial
vaginosis
ESTELLE DEVILLARD
1,2, JEREMY P. BURTON
3, & GREGOR REID
1,2
1Canadian Research and Development Centre for Probiotics, The Lawson Health Research Institute, London, Ontario,
Canada,
2Department of Microbiology and Immunology, University of Western Ontario, London, Ontario, Canada, and
3BLIS Technologies, Centre for Innovation, University of Otago, Dunedin, New Zealand
Abstract
Objective: Gardnerella vaginalis has long been the most common pathogen associated with bacterial vaginosis (BV). We
aimed to test our hypothesis that symptoms and signs of BV do not necessarily indicate colonization by this organism, and
often will not respond to standard metronidazole or clindamycin treatment.
Methods: Using a relatively new molecular tool, PCR denaturing gradient gel electrophoresis (DGGE), the vaginal
microﬂora of a woman with recalcitrant signs and symptoms of BV was investigated over a 6-week timeframe.
Results: The vagina was colonized by pathogenic enterobacteriaceae, staphylococci and Candida albicans. The detection of
the yeast by PCR-DGGE is particularly novel and enhances the ability of this tool to examine the true nature of the vaginal
microﬂora. The patient had not responded to antifungal treatment, antibiotic therapy targeted at anaerobic Gram-negative
pathogens such as Gardnerella, nor daily oral probiotic intake of Lactobacillus rhamnosus GG. The failure to ﬁnd the GG strain
in the vagina indicated it did not reach the site, and the low counts of lactobacilli demonstrated that therapy with this
probiotic did not appear to inﬂuence the vaginal ﬂora.
Conclusions: BV is not well understood in terms of its causative organisms, and further studies appear warranted using
non-culture, molecular methods. Only when the identities of infecting organisms are conﬁrmed can effective therapy be
devized. Such therapy may include the use of probiotic lactobacilli, but only using strains which confer a beneﬁt on the
vagina of pre- and postmenopausal women.
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Introduction
Although bacterial vaginosis (BV) is one of the most
common gynecological problems encountered by
primary care physicians and gynecologists, diagnostic
tools are neither optimal nor convenient. The disease
often presents in asymptomatic form, and is detected
by the dominance of Gram-negative anaerobic
bacteria [1], and in some cases aerobic bacteria [2],
replacing the lactobacilli ﬂora found in healthy
women. Studies in the last decade have established
that BV can be associated with infective complica-
tions, such as preterm labor, post-surgical sepsis and
an increased risk factor of acquisition of sexually
transmitted diseases including HIV [1, 3–5]. The
infections frequently recur after antibiotic treatment.
Indeed, standard therapy with metronidazole or
clindamycin, administered intravaginally or orally,
is followed by relapse in approximately 30% of cases,
within 3 months [6]. Arguably, the inability to
prevent relapses reﬂects a lack of understanding of
the etiology and microbiology of BV.
The diagnosis of BV is based upon symptoms and
signs including vaginal irritation, discharge and ﬁshy
odor, followed by microscopic examination of wet
mounts. Amsel’s criteria [7] or Nugent score [8]
determinations,based onmicroscopic observationsof
swabs, remain the most widely used tests to diagnose
BV.However,thesearelimitedanddonotidentifythe
pathogens, which are presumed to be Gardnerella and
other species such as Mobiluncus [9, 10].
Microbiological techniques, such as bacterial culti-
vation in combination with accurate molecular
identiﬁcation, have aided epidemiological investiga-
tion of BV, but they are logistically demanding for
routineanalysis.Inaddition,becauseofanaerobicand
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microorganisms are difﬁcult to cultivate and some of
them still remain to be cultivated [11]. The use of
molecular techniques, based on polymerase chain
reaction(PCR)andampliﬁcationof16SrDNAseems
to represent a rapid and reliable way to identify
microorganisms. The combination of PCR and
denaturing gradient gel electrophoresis (DGGE)
allows the identiﬁcation of a high number of bacterial
species in the complex ecosystems of the human body
[11–13]. DGGE has been successfully used for
examination of the vaginal ﬂora, including detection
of Gardnerella and so far uncultured species such as
Lactobacillus iners [11, 13]. In the present study, we
demonstrate the complexity of the microﬂora of a
woman with recurrent, symptomatic BV which had
not been resolved by previous antibiotic or probiotic
therapy.
Materials and methods
Subject
A postmenopausal 51-year-old woman (SB) pre-
sented with an 18-month history of recurrent BV not
resolved by various medications (standard treatment
with metronidazole, clarithromycin, antifungals such
as ﬂuconazole and antiseptic solutions such as
hydrogen peroxide and betadine). She reported
having used home-made yogurt and Lactobacillus
rhamnosus GG (10
10 cells per dose, Culturelle,USA)
vaginally and orally, with no detectable improvement
with any of the listed regimens. At the time of the
study, the patient was not receiving any hormones or
antibiotics, but was still ingesting Lactobacillus
rhamnosus GG, one dose daily. Her diagnosis
included three of the four Amsel criteria [7], namely
vaginal irritation, discharge, elevated pH 44.5 and
presence of clue cells in vaginal swab. She signed an
informed consent document approved by the Ethics
Review Board at the University of Western Ontario.
Collection procedure
Vaginal swabs were collected by the subject each
week for 6 consecutive weeks. The swabs were
immediately placed in a transport medium (NCS
Diagnostics) and sent to our laboratory for analysis.
Smears on microscope slides were Gram-stained and
then scored by the method of Nugent et al. [7]:
grades 0 to 3 (normal, N), 4 to 6 (intermediate, I)
and 7 to 10 (high-grade bacterial vaginosis, BV).
Extraction of DNA
Swabs were vigorously agitated in 1 ml of phosphate-
buffered saline (PBS, pH 7.5), and microbial cells
were pelleted by centrifugation (10000 g, 5 min),
and washed once in PBS. Microbial DNA was
extracted using Instagene Matrix (Bio-Rad Labora-
tories, Hercules, CA, USA) according to the
manufacturer’s instructions.
PCR ampliﬁcation of DNA and DGGE
Amplicons of ribosomal bacterial DNA were ob-
tained as described previously by Burton and Reid
[7]. Brieﬂy, 2 ml of DNA extracted from the swabs
were used as the template of the PCR reaction. The
primers used were either eubacterial primers (5’-AC-
TCCTACGGGAGGCAGCAG-3’, 5’-GTATTAC-
CGCGGCTGCTGGCAC-3’) in the case of ampli-
ﬁcation of all ribosomal eubacterial DNA, or
lactobacillus-speciﬁc primers (5’-AGCAGTAGG-
GAATCTTCCA-3’, 5’-CATGTGTAGCGGTGR-
AAT-3’) in the case of the ampliﬁcation of this
speciﬁc genus DNA. For each pair of primers, the
forward primer carried a GC clamp (40 extra bases,
mostly G and C) at its 5’ end.
Preparation of DGGE gel gradients and electro-
phoresis was carried out according to the
manufacturer’s guidelines for the D-Code
TM Uni-
versalDetectionSystemofBio-Rad.A100%solution
was taken as a mixture of 7 M urea and 40%
formamide. The concentrations of polyacrylamide
and denaturant were 8% and 30–50%, respectively.
PCR products were mixed with 26 loading buffer
(0.05% bromophenol blue, 0.05 % xylene cyanol,
70%glycerol)andloadedintothewells.Gelswererun
at 130 V in 16TAE (40 mM Tris, 20 mM acetic
acid, 1mM EDTA, pH 8.0). After electrophoresis,
gels were stained for 20 min in 5 mg/ml of ethidium
bromide and de-stained for 10 min in 16TAE. Gels
were visualized by ultraviolet transillumination.
Band excision from DGGE gels, re-ampliﬁcation and
sequencing
DGGE gel bands were excised using a sterile scalpel,
washed once in 1 6 PCR buffer and incubated in of
the same buffer overnight at 48C; 5 ml of the buffer
solution formed the template for PCR ampliﬁcation.
Re-ampliﬁcation was conducted using either the
eubacterial or lactobacilli PCR primers (with no ‘GC
clamps’) depending on the primer set used in the
DGGE, and with the same conditions as for the PCR
preceding the DGGE analysis. Sequences of the re-
ampliﬁed fragments were determined by the dideoxy
chain termination method (Sequencing Facility, John
P. Robarts Research Institute, London, ON, USA).
Analysis of the partial 16S rRNA sequences was
conducted using the Genbank DNA database and the
BLAST algorithm [14]. Identities of isolates were
determined on the basis of the highest identity score.
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Reference strain Candidia albicans ATCC 76615 was
cultivated on Sabouraud glucose broth or agar (10 g
peptone, 15 g glucose and 150 g agar in 1:l distilled
water, pH 6.8). The DNA was extracted from
washed yeast cells in PBS by using Instagene Matrix
(Bio-Rad Laboratories, Hercules, CA, USA) accord-
ing to the manufacturer’s instructions. The detection
of the yeast was based on the ampliﬁcation of the
gene encoding a heat shock protein 90 gene fragment
of 317 base pairs [15]. For the detection of C.
albicans in the DNA extracted from the swabs, 2 mlo f
template sufﬁced. The PCR reaction was the same as
that described by Crampin and Matthews [15],
except that a touchdown PCR protocol was used to
increase ampliﬁcation speciﬁcity. The annealing
temperature was gradually decreased from 678Ct o
558C for 15 cycles. The detection limit of the yeast
PCR assay was determined by using DNA extrac-
tions from known numbers of C. albicans cells.
Results
Nugent scores
No trichomonads were seen on the vaginal swabs.
The six samples tested for Nugent scores showed
clue cells and high scores between 9 and 10,
conﬁrming high-grade bacterial vaginosis. On micro-
scopy differences were noticed between the six
samples, in that the ﬁrst sample showed a very high
proportion of small Gram-negative rods, and in
samples from following weeks the proportion of rods
decreased as they were replaced by an increasing
percentage of Gram-positive cocci.
DGGE analysis of bacterial DNA from vaginal swabs
using eubacterial-speciﬁc primers
Using DGGE analysis and DNA sequence analysis
of the PCR products from eubacterial-speciﬁc
primers targeting the V2–V3 region of the 16S rRNA
gene, it was possible to identify several bacterial
species present in the vaginal swabs. Overall, seven
different bacterial species were detected: Klebsiella
oxytoca (fragments 1, 6, 9), Serratia fonticola (frag-
ment 2), Citrobacter freundii (fragment 3), Morganella
morganii (fragments 4, 7), Kluyvera ascorbata (frag-
ment 5), Escherichia coli (fragment 10) and
Staphylococcus epidermis (fragment 8) (Figure 1).
The homology between the sequence obtained from
the DGGE bands and the closest species from the
database are given in Table I. The DGGE patterns
for the ﬁrst three samples seemed to be quite
different to each other, showing an unstable ecosys-
tem. However, for the last 3 weeks of analysis the
DGGE pattern appeared stable. The ﬁrst sample
contained three bacterial species: Klebsiella oxytoca,
Serratia fonticola and Citrobacter freundii. On the
second week, these three strains were no longer
detectable and the microﬂora was dominated by a
Morganella morganii strain. This organisms were then
detected in all subsequent samples and represented
the most intense band overall. Two additional bands,
corresponding to Klebsiella oxytoca and Kluyvera
ascorbata, were detected on week 3. Samples from
weeks 4 to 6 showed similar patterns with four
different bacterial species: Klebsiella oxytoca, Morga-
nella morganii, Escherichia coli and Staphylococcus
epidermis. These ﬁndings correlated with microscopic
observations, namely a predominance of Gram-
negative rods and Gram-positive cocci.
Interestingly, the sequencing of the DGGE bands
did not reveal the presence of Gardenella vaginalis,
Mycoplasma hominis, Mobiluncus sp. or Prevotella sp.
whichhavegenerallybeenassociatedwithcasesofBV.
Using eubacterial primers, no DGGE bands
corresponded to lactobacillus strains, which are
normally present in the healthy vaginal microbiota.
This absence of lactobacilli reﬂected the high Nugent
scores of the subject’s samples. However, use of
Lactobacillus-speciﬁc primers (Figure 2) did detect
ﬁve different Lactobacillus strains. These comprised
Lactobacillus sp. GFTH5 (closest species being L.
johnsonii), Lactobacillus johnsonii, Lactobacillus gasseri,
Lactobacillus delbrueckii and Lactobacillus reuteri. The
unidentiﬁed lactobacilli were dominant in each
weekly sample, whereas Lactobacillus sp GFTH5
(L. johnsonii), L. delbrueckii, L. johnsonii and L. gasseri
Figure 1. DGGE proﬁles of the total vaginal microbiota from the
subject during the 6 weeks of study (lanes 1 to 6=weeks 1 to 6).
See Table I for bacterial species associated with the arrowed bands
shown here.
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The DGGE patterns on weeks 4 to 6 were very faint
for lactobacilli and only Lactobacillus reuteri was
identiﬁed on week 6. Among the ﬁve sequences
retrieved from the PCR-DGGE, none of them
corresponded to the Lactobacillus rhamnosus GG
strain present in the probiotic product that the
subject was taking orally on a daily basis.
Candida albicans detection
The speciﬁcity of the PCR for detection of C. albicans
was conﬁrmed by DNA sequencing of the PCR
products obtained with a C. albicans control strain.
The limit of detection was also determined using this
PCR method, with a minimum of 100 cells being
detected (Figure 3). Candida albicans was detected in
weeks 1, 2, 4 and 5. The intensity of the PCR
fragments from the samples from weeks 1, 2 and 5
was very low, whereas that of fragments from the
week 4 sample was intense (between 100 and 1000
cfu/ml, Figure 3).
Discussion
The present study of multiple vaginal samples from a
woman with complicated vaginitis, provides valuable
insight into difﬁcult cases faced by gynecologists on a
regular basis. The bacterial species detected by
DGGE using eubacterial PCR primers were all
potential urogenital pathogenic species [9, 16, 17].
Morganella morganii and Escherichia coli, detected in
multiple samples, are not generally regarded as
speciﬁc causes of BV [18], although they are well
known for causing UTI [17] and E. coli have been
associated with aerobic BV [2]. Staphylococcus
epidermis was detected in the three last samples from
the subject. This skin commensal is not normally a
pathogenic species, but can take advantage of
immunodeﬁciency, or abnormalities in the urogen-
ital tract and can cause UTI [17]. Even although the
patient was diagnosed with recurrent BV, no
Gardnerella vaginalis were detected, nor were any of
the other species normally associated with this
disease, namely Mobiluncus sp., Mycoplasma hominis,
and Prevotella sp. [1]. This ﬁnding demonstrates the
complexity of complicated vaginitis and the difﬁcul-
ties in conﬁrming its diagnosis. It also agrees with a
recent study that showed that post-menopausal
subjects not receiving estrogen replacement therapy
can have BV without G. vaginalis [11]. Other studies
show that non-gardnerella organisms cause BV [19]
Table I. BLAST analysis of vaginal bacterial and lactobacilli 16SrRNA sequences of excised fragments from DGGE gels. +:band detected
on the DGGE gel, -:band not detected on the DGGE gel, +/7:weak signal on the DGGE gel.
Species Homology
Band
number W1 W2 W3 W4 W5 W6
Klebsiella oxytoca AF390083 87% 1, 6, 9 + - + + + +
Serratia fonticola AF511435 100% 2 + - - - - -
Citrobacter freundii CFR233408 98% 3 + - - - - -
Morganella morganii AF461011 98% 4, 7 - +++++
Kluyvera ascorbata AF310219 92% 5 - - + - - -
Escherichia coli CFT073 AE016770 98% 10 - - - + + +
Staphylococcus epidermidis AF397060DO 92% 8 - - - + + +
Lactobacillus sp. GTH5 AF157033 95% 1, 6 + + + +/7 -+
Lactobacillus johnsonii AY186044 95% 3 + + - - - -
Lactobacillus gasseri AY190619 94% 2, 5 + + + - - -
Lactlbacillus delbruecki AF375917 92% 4, 8 + + - +/7 ++
Lactobacillus reuteri LR16SRRI 96% 7 - - - +/7 -+
W1=week 1 of sampling etc.
Figure 2. DGGE proﬁles of the vaginal lactobacilli population
from the subject during the 6 weeks of the study (lanes 1 to
6=weeks 1 to 6). See Table I for Lactobacillus species associated
with the arrowed bands shown here.
28 E. Devillard et al.and these bacteria can form dense bioﬁlms [20] on
vaginal cells, indicative of what is seen on clue cells
examined under the microscope.
Given that BV treatment usually comprises anti-
biotics against anaerobic Gram negative bacteria,
several scenarios are possible. Metronidazole treat-
ment may have effectively eradicated infecting
anaerobes prior to the patient being entered in our
study, in which case the ability of Staphylococcus
epidermis and Enterobacteriaceae to induce symptoms
and signs of recurrence of BV is a ﬁnding that
warrants further investigations. This scenario is less
plausible as the subject ceased antibiotic use prior to
entering the study. If the patient never had anaerobic
pathogens as the prime cause of her BV presentation,
then this might explain previous antibiotic failures,
and it raises the question of how best to conﬁrm
diagnosis of the disease. While it is feasible that
Gardnerella and other anaerobes may have been
present and not detected by PCR-DGGE, it is
unlikely over the six week study, and if these
organisms were present in such low numbers it is
doubtful that they played a major role in the patients’
condition. Furthermore, the DGGE method has
been shown by us to be a suitable method to detect
even low levels of Gardnerella [11, 13]. It could be
argued that we should have attempted to recover
Gardnerella by culture, but given the difﬁculty to
recover and quantify anaerobes by culture, and the
obvious low numbers present if any, we did not feel
that this would have signiﬁcantly altered the overall
ﬁndings.
DGGE analysis of eubacterial amplicons did not
lead to the detection of any Lactobacillus species.
However, PCR using species-speciﬁc primers did
identify lactobacilli in low numbers. This suggests a
deﬁciency in the Nugent scoring system which scores
BV based upon the absence of lactobacilli. While
these organisms may indeed be ‘absent’ under
microscopy (which generally requires around 10
4
bacteria per ml in the suspension being examined
under the microscope), they may in fact not be
totally absent from the vaginal vault. This offers hope
for recovery of the patient, as stimulation of the
indigenous lactobacilli (through use of prebiotics, or
creation of a suitable microenvironment by exogen-
ous lactobacilli application) [21] could lead to
recovery and dominance of the lactobacilli ﬂora.
Studies have shown that select strains of Lactobacillus
can colonize the vagina and inhibit the growth and
adhesion of various pathogens [22–25]. The failure
of Lactobacillus rhamnosus GG therapy to lead to its
colonization of the vagina and correction of the BV,
could have several explanations. Ingestion of this
organism has failed in previous studies to make an
impact on the urogenital ﬂora and patient health [26,
27], while direct intravaginal application has not led
to long term colonization [28]. On the other hand,
the patient here is post-menopausal, and in such
cases lactobacilli are often not present without
estrogen replacement therapy [29], and it is possible
that only select probiotic strains would colonize. The
fact that lactobacilli were recovered from the vagina
of this patient, supports the view that Lactobacillus
rhamnosus GG [27] is not the most appropriate
probiotic for patients with recurrent BV or chronic
vaginitis.
Of the lactobacilli detected in the vagina, none
were from the yogurt cultures consumed by the
patient, and of those cultures only L. gasseri has
been found to be somewhat common in post-
menopausal subjects [11]. The most commonly
isolated strain in healthy women after menopause,
L. iners, was not detected in this subject. Under-
standing why certain lactobacilli exist in different
subjects remains a topic requiring much additional
investigation.
PCR proved to be an easy and reliable way to
determine the presence of yeast, a common cause of
vaginal infections [15, 30]. The extent to which C.
albicans, contributed to the patient’s condition is
unknown, but the levels in week 4 were consistent
with a transient yeast infection. While the study was
not designed to provide a clinical cure for the
subject, it is possible that she will require mechan-
ical, chemical and anti-microbial treatment as
Figure 3. Detection of Candida albicans by PCR in the vagina of the subject during the six weeks of the study. Lanes 1 and 12=100 bp
ladder. Lanes 2 to 7=weeks 1 to 6. Lanes 8 to 11=detection of C. albicans from a known number of yeast cells (respectively 10000, 1000,
100 and 0 cfu/ml).
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eradicating the isolated pathogens.
In summary, this study showed that molecular
techniques represent an excellent tool to identify the
pathogenic microorganisms involved in recurrent
BV. Current microscopic wet mount analysis is
useful to assess the level of infection, while culture
may not be sufﬁcient to adequately guide effective
treatment. Until techniques such as PCR-DGGE
and sequencing become widely available in diag-
nostic laboratories, and routine microbiology labora-
tories more effectively recover fastidious anaerobes
from vaginal swabs, physicians will not have ade-
quate information to best diagnose and treat their
patients. In this present case, use of metronidazole or
clindamycin, the standard agents to treat BV, will
only result in failure.
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